Hericerionol A Synthesis via Isoindolinone Intermediates
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for a novel process to synthesize the compound 4-hydroxy-5-(2-hydroxyethyl)-6-methoxy-2-phenethylisoindolin-1-one, also known as Hericerionol A, which is isolated from the Hericium erinaceus mushroom, as a potential therapeutic agent for neurological diseases by promoting nerve growth factors, as existing methods are lacking.
Innovation Solution
A multi-step synthetic process involving Mannich reaction, acid-base reaction, allyl halide reaction, Claisen rearrangement, oxidation, reduction, and deprotection steps, using specific reagents and solvents, to produce the compound.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If a multi-step synthetic process is used to prepare Hericerionol A, then the compound can be synthesized with high purity and correctness, but the process complexity and time consumption increase significantly
Solution Approach 1:
The synthesis process is divided into distinct sequential steps: Mannich reaction to form the isoindolinone core, acid-catalyzed rearrangement to establish the correct skeletal structure, and selective oxidation to introduce hydroxyl groups. Each step is optimized independently to ensure high purity and correctness while managing overall process complexity.
Solution Approach 2:
The Mannich reaction is performed first to pre-form the isoindolinone core structure with correct stereochemistry before subsequent transformations. This preliminary structuring ensures that later steps proceed with high fidelity to the target molecule's final configuration.
2Manufacturing precision
If multiple reaction steps are performed to synthesize Hericerionol A, then the desired compound structure is achieved, but the production time and process duration increase
Solution Approach 1:
The synthesis protocol employs continuous sequential reactions where each step flows into the next without unnecessary interruptions. The acid-catalyzed rearrangement immediately follows the Mannich reaction, and oxidation proceeds directly after intermediate isolation, minimizing idle time while maintaining structural accuracy.
Solution Approach 2:
Reaction conditions are systematically adjusted between steps (temperature, pH, reagent concentration) to optimize each transformation's efficiency and speed. The acid-catalyzed rearrangement uses specific pH conditions to accelerate the skeletal reorganization, reducing the time required for this critical structural transformation.
3Ease of manufacture
If conventional synthesis methods are used, then the process may be simpler, but there is no known process for preparing Hericerionol A from natural sources
Solution Approach 1:
The patent employs specific intermediary compounds during the synthesis pathway, including Mannich base intermediates and acid-catalyzed rearrangement products, that serve as reliable bridges from readily available starting materials to the target Hericerionol A structure. These intermediates have been characterized and validated to ensure synthesis feasibility.
Solution Approach 2:
The synthesis method utilizes controlled changes in reaction parameters (pH, temperature, solvent conditions) to enable transformations that are not achievable under conventional conditions. The acid-catalyzed skeletal rearrangement specifically requires controlled acidic conditions to proceed reliably, establishing a feasible synthetic pathway where none existed before.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process efficiently synthesizes Hericerionol A, enabling its use as a therapeutic agent for neurological diseases by promoting nerve growth factor generation.
Implementation Method 1
the compound of Formula 2 may be prepared by performing a Mannich reaction on a methyl 3-hydroxy-5-methoxybenzoate compound. For example, the Mannich reaction may be a reaction of the methyl 3-hydroxy-5-methoxybenzoate compound with phenylethylamine and formaldehyde.
Implementation Method 2
The present invention also provides a process for preparing the compound of Formula 3. In one embodiment, the compound of Formula 3 may be prepared by reacting the compound of Formula 2 with an acid and then reacting with a base.
Implementation Method 3
The present invention also provides a process for preparing the compound of Formula 5. In one embodiment, the compound of Formula 5 may be prepared by performing a Claisen rearrangement reaction on the compound of Formula 4
Data Source
AI summary
The present invention relates to a process for preparing an isoindolinone derivative represented by Formula 1, novel intermediates used for the process and a process for preparing the intermediates.